The development of the nervous system is a highly organized process where bipolar neuroepithelial cells play a key role. During neurogenesis these cells divide to expand the neural progenitor pool and generate differentiated neural cells. Their cell cycle is coordinated with the apicobasal interkinetic nuclear migration in such a way that mitosis occurs in the apical membrane. 1, 2 It is believed that external developmental cues, epigenetic mechanisms and cell cycle regulators might be linked in order to coordinate these processes. Although apicobasal polarity is known to influence self-renewal at early neurogenesis, 3 the exact molecular mechanisms underlying this coordination program remain unclear.
During the last decade, great efforts have been made to elucidate the role of epigenetic regulators that govern different aspects of neural development. The epigenetic control, understood as the heritable changes in genome activity that do not involve alteration of the DNA sequence, is mainly mediated by covalent modifications of histones and DNA. 4 Recently, histone methylation has received special attention as an essential regulator of gene expression. In particular, methylation of lysine 27 of histone H3 (H3K27me3) has been found to be an important regulator of embryonic development. 5 The enzymes responsible for this activity are Enhancer of Zeste Homolog's 1 and 2 (EZH1/2) 6 that belong to the Polycomb Repressive Complex2 (PRC2). H3K27me3 is recognized by Polycomb proteins leading to transcriptional repression of many developmental regulators. [7] [8] [9] This mark is removed by JMJD3 and UTX demethylase activity. [10] [11] [12] [13] H3K27me3 has shown to play a role in hereditary transmission of chromatin states and structure. Although it is still unclear how H3K27me3 levels are restored after several DNA replication rounds and mitosis, it has been proposed that the unmodified newly synthetized histones incorporated in the daughter strands get the H3K27me3 mark through the recruitment of PRC2 to the older H3K27me3. This mechanism also accounts for mitosis, maintaining H3K27me3 at targets genes through the cell cycle 14 and allows to preserve transcriptional programs and cellular identity during development.
PRC2 controls proliferation of progenitors cells, in part by repressing of the Ink4A/Arf locus, [15] [16] [17] and regulates cellular differentiation. 8, 16, 18, 19 In addition to its role as an epigenetic factor, EZH2 cooperates with different signals in the cytoplasm to allow actin reorganization. 20 Although the function of EZH2 as a transcriptional repressor is well characterized, its role during vertebrate development, and particularly in neurogenesis, is just emerging.
EZH2 in neurogenesis
Research efforts in the last decade have highlighted the relevance of EZH2 and Polycomb proteins in a wide range of neurogenic processes. During the development of the cerebral cortex, conditional deletion of Ezh2 at early embryonic stages induces premature neuronal differentiation, which leads to a decreased number of neurons at birth. 21 At later stages, EZH2 and Polycomb proteins repress Ngn1 expression. By doing so Polycomb proteins regulate the timing of neurogenic to astrogenic fate switch that occurs as the cortex develops. 22 In addition to its role in the cerebral cortex EZH2 is a critical player in the development of the cerebellum. Ezh2 is highly expressed in the cerebellar primordium as early as embryonic day E10.5 and regulates transcription of multiple genes involved in proliferation of progenitor cells and differentiation of cerebellar neuronal lineages. Accordingly, deletion of Ezh2 in the dorsal neural tube, leads to underdevelopment of the cerebellum. 23 But the function of EZH2 in hindbrain development goes even further. The use of a sophisticated combination of genetic tools has recently revealed a complex role of EZH2 in precerebellar neuron migration, mostly mediated by the transcriptional regulation of the guidance ligand-receptor molecules in migrating cells and their environment. Either the deletion of Ezh2 from the migrating precerebellar neurons or from the surrounding neural tube cells alters their final localization and connectivity. 24 More recently, an essential role of EZH2 in adult neurogenesis has been reported. In hippocampal neural progenitor cell EZH2 regulates proliferation by suppressing Pten expression and promoting the activation of Akt-mTOR. As a consequence, conditional deletion of Ezh2 results in defective hippocampal neurogenesis and impaired spatial learning and memory. 25 Furthermore, EZH2 is also required for fate determination of adult neural progenitor cells. Although functional relevance in humans is still unknown, EZH2 expression was found in adult neural progenitor cells suggesting that EZH2 might be key for postnatal human neurogenesis as well.
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EZH2 in the spinal cord development
Our recent report provides new insight into the EZH2 function at early neurogenesis in the spinal cord, revealing a new mechanism that coordinates neuroblast proliferation and neuroepithelium (NE) structure. 27 We observed that EZH2 is highly expressed in the ventricular zone of the chicken neural tube, where the neuroblasts reside, and dramatically decreased in the mantle zone, where the differentiated neurons accumulate. By in ovo electroporation of specific shRNAs, we depleted EZH2 resulting in a small neural tube. The reduced size was due to the blocking of selfrenewal of neuroepithelial cells and cell death by apoptosis. Remarkably, the EZH2 knock down (K D ) embryos showed, in addition, a structurally disorganized neural tube: the apical membrane was severely disrupted along the luminal surface, and a subset of cells lost the apical junctions and invaded the neural tube lumen. Moreover, functional, ectopic lumens were observed in the EZH2 K D neural tubes.
It is well established that Rho signaling pathway couples developmental signals downstream cytoskeletal rearrangements and cell proliferation. 28 Interestingly, Rho pathway is subjected to a strict spatiotemporal regulation in the neural tube 29 and it is repressed at early embryonic neural tubes. 30, 31 These data led us to test whether EZH2 could affect the NE structure by regulating Rho activity at the early stages of neurogenesis. Our results indicated that the observed structural alterations were concomitant with increased Rho activity in the EZH2 depleted embryos. These data reveal an unexpected new role of EZH2: in addition to allow the self-renewal and survival of neural progenitor cells, EZH2 is required to maintain apicobasal polarity and NE integrity.
EZH2-mediated p21
WAF1/CIP1 expression coordinates apicobasal polarity and cell proliferation
To gain insight into the role of EZH2 on progenitor self-renewal and NE apicobasal polarity at a molecular level, we analyzed the EZH2-mediated transcriptional profile by microarray experiments. We found that p21
, a well-known tumor suppressor gene, was highly up regulated in EZH2 K D neural tubes. Interestingly, restoration of p21 WAF1/CIP1 levels in EZH2 depleted embryos rescued not only proliferation defects but also many of the NE structural alterations and partially restored the Rho activity levels. Moreover, we demonstrated that cytoplasmic p21 WAF1/CIP1 (but not the nuclear p21 WAF1/CIP1 ) induced the formation of ectopic and functional lumens, similar but milder to those observed in EZH2 depleted neural tubes. Our data suggested that the increase on Rho activity mediated by EZH2-depletion was partially due to high levels of p21 WAF1/CIP1 . However, the partial rescue of Rho activity by p21 WAF1/CIP1 depletion, and the milder NE structural defects by electroporation of cytoplasmic p21 WAF1/CIP1 indicated that additional factors might contribute to Rho activity in EZH2 depleted spinal cord. Consistent with this, the expression arrays showed that some Rho family members, RhoBTB2, and ARHGAP10 were regulated by EZH2. Moreover, EZH2 non transcriptional effects need to be taken into account, since cytoplasmic EZH2 regulates actin polymerization by interacting with vav1, an activator of RhoA GTPase signaling. 20 One of the unsolved questions in early neurogenesis is how neural tube structure and cell renewal are coordinated. Our results bring light to this problem. At early stages of development, EZH2 keeps silenced some Rho signaling components and the cell cycle regulator p21 WAF1/CIP1 . By doing so, EZH2 allows the establishment of apicobasal polarity that ensures proper cell renewal (Fig. 1) . Future investigations of this model will provide additional data of the process by which p21 WAF1/CIP1 regulates the Rho signaling pathway and the contribution of non transcriptional role of EZH2 on Rho activity regulation as has been previously proposed. 20 Implications for medicine in central nervous system EZH2 is well known by its role as an oncogene. More than a decade ago, the overexpression of EZH2 was associated with prostate cancer malignancy. 32 Since then, multiple studies have shown that high levels of EZH2 correlate with tumor cell proliferation, aggressive behavior and poor prognosis in a wide range of cancers, including primary brain tumors. [33] [34] [35] For instance, overexpression of EZH2 correlates with poor prognosis of glioblastoma, 35 one of the most aggressive primary brain tumors due to its rapid progression and invasiveness. EZH2 is indeed necessary for maintenance and self-renewal of glioblastoma cancer stem cells, since its pharmacological inhibition or depletion with interference RNA impairs proliferation and tumor initiation capabilities of the glioblastoma cancer stem cells. Additional studies on medulloblastoma, ependidoma and neuroblastoma have revealed that EZH2 overexpression is commonly found in adult and pediatric primary brain tumors as well. 33 According to most of the reported studies, molecular mechanism underlying oncogenic activity of EZH2 points toward its methyltransferase activity on H3K27 and consequent target gene repression. Although p16 INK4A /p19
ARF locus was one of the first Polycomb targets found misregulated in a mouse model of glioma 36 most recent transcriptional profiling studies have identified additional groups of EZH2 target genes involved in cell cycle regulation, stem cell differentiation and cellular migration. 33 However, just a handful of these genes, have been shown to act as effectors of EZH2 oncogenic activity in brain tumors. Frequently, these effectors are also regulated by EZH2 in neural stem cells during embryonic development. This is the case of BMPR1B, which progressive expression promotes astrocyte differentiation from neural stem cells during development, but persistent repression by EZH2 in glioblastoma stem cells contribute to tumor cell proliferation and maintenance. WAF1/CIP1 at the ventricular zone of the neural tube. In this way, EZH2 ensures the correct establishment of apicobasal polarity that allows the neuroepithelial cell self-renewal (left panel). In EZH2 depleted embryos, an increased Rho activity due to low EZH2 activity and increased p21 WAF1/CIP1 levels leads to a structurally altered neural tube where the neuroblasts do not proliferate (right panel). Red dots on the chromatin indicate H3K27me3. Darker areas on the neural tube refer to differentiated neurons.
H3K27 methyltransferase activity of EZH2 is also fundamental in the chicken embryo spinal cord. As we observed, EZH2 guarantees neural stem cell selfrenewal and proliferation, in part, by repressing p21 WAF1/CIP1 expression. In addition to their oncogenic and tumor suppressor activity respectively, EZH2 and p21 WAF1/CIP1 have antagonistic roles on senescence. 38 Cellular senescence is an irreversible growth arrest induced by cellular damage or stress conditions. Consistent with its role as a tumor suppressor mechanism, senescence in premalignant tumors avoid progression of tumorigenesis, and inactivation of senescence activating proteins, typically p16 CDKN2A , is found in full-blown cancers. [39] [40] [41] However, recent findings indicate that developmental cues also activate senescence during embryogenesis contributing to the development and morphogenesis of multiple embryonic tissues. 42, 43 Interestingly, one of the major players of developmental senescence is p21 WAF1/CIP1 . But does this have any relevance for the nervous system development and diseases?
Other than the presence of senescent cells that correlates with p21 WAF1/CIP1 expression, 42 little is known about the role of senescence in the neural tube development. Preliminary data from our lab indicates that p21 WAF1/CIP1 is expressed in the mantle zone, where we also observed postmitotic senescent neural cells. Although senescence was not evaluated in EZH2 K D neural tubes, through p21 WAF1/CIP1 repression in the ventricular zone, EZH2 might act blocking senescence. Indeed, several aspects of the phenotype we observe knocking down EZH2 could result from the activation of senescence, for example, the non-cell autonomous behavior of certain Tuj1 positive differentiated cells or migration of cells that invade the lumen. One of the hallmarks of senescent cells is the senescence associated secretory phenotype (SASP) that allows signaling from senescent cells to the external environment through the secretion of growth factors, cytokines/ chemiokines and extracellular remodeling factors. In some cases SASP has been implicated in epithelial mesenchymal transition (EMT) and invasion of neighboring cells. 44 EMT is one of the first steps that a tumor cell undergoes to become metastatic. This process requires loss of epithelial polarity and cell adhesion, typically triggered by repression of cell adhesion molecules like E-cadherin. The repression of E-cadherin by EZH2 is well established in a variety of tumors, including prostate, breast and melanoma. 45, 46 Likewise, corepression of E-cadherin by Snail and EZH2 is also a key step for migration of neural crest cells during development. 47 In the ventricular zone of the developing embryo however, loss of neuroepithelial structure is driven by EZH2 depletion and consequent induction of Rho GTPase activity by cytoplasmic p21 WAF1/CIP1 as our work has revealed. Moreover, we also found additional Rho GTPase family members activated by EZH2 K D that could contribute to the loss of neuroepithelial structure and invasive behavior of certain cells in our model. Hence, our work suggests a counter intuitive tumorigenic mechanism of EZH2 depletion. Indeed, homozygous or heterozygous deletions of EZH2 are common in malignant myeloid diseases; [48] [49] [50] and both activating and inactivating mutations of EZH2 are related to malignancy. 51, 52 Although inactivating EZH2 mutations are not found in brain tumors yet, lysine to methionine mutations of the residue 27 of the histone H3 tail, are recurrently found in several aggressive pediatric brain tumors, likely resembling consequences of EZH2 depletion. 53 In addition, knockout of EZH2 cells with Ink4a/Arf locus deletion do not inhibit cell proliferation and de-represses Olig2, an oncogenic driver of glial tumors. 26 Moreover, EZH2 positive tumors, including glioblastoma tumor cells, develop resistance to pharmacological inhibition of EZH2, 54 suggesting that persistent repression of EZH2 can also contribute to malignancy. Thus, the observation that EZH2 regulates the activity of Rho GTPase and the tumor suppressor p21 WAF1/CIP1 expression opens new avenues to fully understand the role of EZH2 in cancer and metastasis.
Clinical relevance of EZH2, however, goes beyond its oncogenic activity. Recent work identified that high levels of EZH2 and H3K27me3 are present in the cerebellum of Ataxia Telangiectasia patients, a devastating condition caused by ATM protein kinase deficiency. Remarkably, reduction of EZH2 levels rescued Purkinje cell degeneration and behavioral defects of an Ataxia Telangiectasia mouse model, pointing toward a promising future therapeutic strategy for these patients. 55 In summary, our work uncovers an intricate crosstalk between factors that modify chromatin, cell cycle and cell polarity factors that fine-tune spinal cord development. We have described a new role for EZH2 regulating cell renewal and neuroepithelial structure in the spinal cord. Underlying molecular mechanisms that our work revealed will hopefully provide new opportunities to target context dependent EZH2 function in different physiological and pathological conditions.
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